HCPCS Level II drug code
Q9956 — Injection, octafluoropropane microspheres, per ml
In short
Q9956 is the HCPCS Level II code for injection, octafluoropropane microspheres, per ml. CMS assigns NDCs for Optison to it. The Medicare Part B payment limit is $40.323 per unit (October 1, 2026 through December 31, 2026).
Code
CMS HCPCS file- Descriptor
- Injection, octafluoropropane microspheres, per ml
- Short descriptor
- Inj octafluoropropane mic,ml
- Code set
- HCPCS Level II, maintained by CMS
- Effective
- Apr 1, 2005
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Units and claim line
Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.
Enter the units to build the claim line.
NDCs billed under Q9956
CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 2 NDCs to Q9956 for Optison. Billing units per package are CMS’s figures for this code’s unit.
| Drug | NDC (11-digit) | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| Optison | 00407-2707-03 | GE Healthcare Inc. | 5 × 3 | 15 |
| Optison | 00407-2707-18 | GE Healthcare Inc. | 18 × 3 | 54 |
Q9956: common questions
- Is Q9956 a CPT code?
- No. Q9956 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What NDCs are billed under Q9956?
- CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 2 NDCs under Q9956, for Optison. The table on this page shows each one with its billing units per package.
- What is the Medicare payment limit for Q9956?
- $40.323 per 1 ml, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.